ATE449345T1 - Monitorierung von huntington's disease - Google Patents

Monitorierung von huntington's disease

Info

Publication number
ATE449345T1
ATE449345T1 AT05820667T AT05820667T ATE449345T1 AT E449345 T1 ATE449345 T1 AT E449345T1 AT 05820667 T AT05820667 T AT 05820667T AT 05820667 T AT05820667 T AT 05820667T AT E449345 T1 ATE449345 T1 AT E449345T1
Authority
AT
Austria
Prior art keywords
swissprot acc
acc
protein
swissprot
precursor
Prior art date
Application number
AT05820667T
Other languages
English (en)
Inventor
Nicola Leeds
Malcolm Ward
Emma Mcgregor
Sarah Tabrizi
Annette Dalrymple
James Campbell
Jules Westbrook
Helen Byers
Original Assignee
Electrophoretics Ltd
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Electrophoretics Ltd, Univ London filed Critical Electrophoretics Ltd
Priority claimed from PCT/GB2005/004700 external-priority patent/WO2006061610A2/en
Application granted granted Critical
Publication of ATE449345T1 publication Critical patent/ATE449345T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05820667T 2004-12-07 2005-12-07 Monitorierung von huntington's disease ATE449345T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0426859.5A GB0426859D0 (en) 2004-12-07 2004-12-07 Diagnosis of neurodegenerative disorders
GBGB0521762.5A GB0521762D0 (en) 2004-12-07 2005-10-25 Diagnosis of neurodegenerative disorders
PCT/GB2005/004700 WO2006061610A2 (en) 2004-12-07 2005-12-07 Diagnosis of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
ATE449345T1 true ATE449345T1 (de) 2009-12-15

Family

ID=34073345

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05820667T ATE449345T1 (de) 2004-12-07 2005-12-07 Monitorierung von huntington's disease
AT05823285T ATE471519T1 (de) 2004-12-07 2005-12-07 Diagnose neurodegenerativer krankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05823285T ATE471519T1 (de) 2004-12-07 2005-12-07 Diagnose neurodegenerativer krankheiten

Country Status (5)

Country Link
US (2) US9028801B2 (de)
AT (2) ATE449345T1 (de)
DE (2) DE602005017819D1 (de)
ES (2) ES2333892T3 (de)
GB (2) GB0426859D0 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3358354B1 (de) 2008-01-18 2020-07-15 President and Fellows of Harvard College Verfahren zur detektion von anzeichen einer krankheit oder eines leidens in körperflüssigkeiten
WO2012012694A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
BR112013001752A2 (pt) 2010-07-23 2016-05-31 Harvard College método de detectar doenças ou condições usando células fagocídicas
EP2596353A4 (de) 2010-07-23 2014-01-15 Harvard College Verfahren zum nachweis pränataler oder schwangerschaftsvermittelter krankheiten oder leiden
BR112013001754A2 (pt) 2010-07-23 2016-05-31 Harvard College método para detectar marcas de doença ou condições em fluídos corpóreos
EP2592421B1 (de) * 2011-11-14 2017-08-30 Universitätsklinikum Jena Diagnose von blutvergiftung und des systemischen entzündungsreaktionssyndroms
WO2013188828A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
CA2876731A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
EP3693742B1 (de) 2014-09-11 2022-04-06 Harry Stylli Verfahren zum nachweis von prostatakrebs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824988B2 (en) 2000-05-15 2004-11-30 R.E.D. Laboratories, N.V. Method and compositions for use in diagnosing and characterizing chronic immune disease
GB0026604D0 (en) * 2000-10-31 2000-12-13 Roslin Inst Edinburgh Diagnostic method
EP1799861A2 (de) * 2004-09-20 2007-06-27 Proteogenix, Inc. Diagnose einer fötalen aneuploidie
GB0421639D0 (en) * 2004-09-29 2004-10-27 Proteome Sciences Plc Methods and compositions relating to alzheimer's disease
US7704708B2 (en) * 2006-02-13 2010-04-27 Uti Limited Partnership Monomeric streptavidin muteins

Also Published As

Publication number Publication date
ES2333892T3 (es) 2010-03-02
DE602005021912D1 (de) 2010-07-29
ES2344118T3 (es) 2010-08-18
GB0426859D0 (en) 2005-01-12
GB0521762D0 (en) 2005-11-30
ATE471519T1 (de) 2010-07-15
US20080286263A1 (en) 2008-11-20
US20080213802A1 (en) 2008-09-04
DE602005017819D1 (de) 2009-12-31
US8506957B2 (en) 2013-08-13
US9028801B2 (en) 2015-05-12

Similar Documents

Publication Publication Date Title
ATE449345T1 (de) Monitorierung von huntington's disease
WO2006061609A3 (en) Diagnosis of neurodegenerative diseases
NL301089I2 (nl) imlifidase
WO2005016127A3 (en) Prion-specific peptide reagents
WO2006086799A3 (en) Prion-specific peptide reagents
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
ECSP066526A (es) Anticuerpos que se unen al receptor de interleuquina-4
WO2008001224A3 (en) Polypeptides from neisseria meningitidis
DK1626985T3 (da) Generering af kunstige bindingsproteiner på basis af ubiquitin proteiner
DE60135498D1 (de) Produktion von ganzen Antikörpern in prokaryontischen Zellen
WO2008008482A3 (en) Altered br3-binding polypeptides
WO2005016132A3 (en) Diagnostics for sars virus
WO2005056585A3 (en) Sars coronavirus s proteins and uses thereof
PT1214600E (pt) Determinacao de proteinas de ligacao a adrenomedulina
WO2008060634A3 (en) Human complement c3 derivatives with cobra venom factor-like function
EP1181554A4 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
ATE517629T1 (de) Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
WO2006044107A3 (en) Method of treating human preeclampsia employing resibufagenin
WO2005004894A3 (en) Methods for increasing cell and tissue viability
Parambeth et al. Purification and partial characterization of α1-proteinase inhibitor in the common marmoset (Callithrix jacchus)
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
WO2007084236A3 (en) Human gene associated with diabetic retinopathy
WO2005005471A3 (en) Use of dg153 secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
ATE489634T1 (de) In vitro methode zur klinischen diagnose.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties